Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy MeiraGTx (MGTX) stocks in Canada

Learn how to easily invest in MeiraGTx stocks.

MeiraGTx is a biotechnology business based in the US. MeiraGTx stocks (MGTX.US) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $15.25 – a decrease of 14.12% over the previous week. MeiraGTx employs 271 staff and has a trailing 12-month revenue of around $20.4 million.

How to buy shares in MeiraGTx

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – MGTX – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Is it a good time to buy MeiraGTx stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

How has Coronavirus impacted MeiraGTx's stock price?

Since the stock market crash in March caused by coronavirus, MeiraGTx's stock price has had significant positive movement.

Its last market close was $18.49, which is 0.92% up on its pre-crash value of $18.32 and 109.64% up on the lowest point reached during the March crash when the stocks fell as low as $8.82.

If you had bought $1,000 worth of MeiraGTx stocks at the start of February 2020, those stocks would have been worth $511.87 at the bottom of the March crash, and if you held on to them, then as of the last market close they'd be worth $954.08.

MeiraGTx stock price (NASDAQ:MGTX)

Use our graph to track the performance of MGTX stocks over time.

MeiraGTx shares at a glance

Information last updated 2022-01-11.
Latest market close$18.49
52-week range$11.60 - $24.90
50-day moving average $20.49
200-day moving average $15.84
Wall St. target price$36.57
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-1.86

Compare online stock trading platforms

Note: The dollar amounts in the table below are in Canadian dollars.

Name Product Finder Rating Stock Trading Fee Account Fee Available Asset Types Feature Table description
Wealthsimple Trade
Finder Rating:
3.9 / 5
Stocks, ETFs
Get 2 free stocks (total value up to $9,000) when you deposit and trade $150.
Pay no commissions when you trade Canadian stocks and ETFs with Wealthsimple Trade.
Scotia iTRADE
Finder Rating:
3.8 / 5
$4.99 - $9.99
Bonds, Options, Mutual Funds, ETFs, GICs, International Equities
Buy, sell and trade ETFs, Equities, Options and more with competitive commissions.
Interactive Brokers
Finder Rating:
4.1 / 5
Min. $1.00, Max. 0.5%
Stocks, Bonds, Options, ETFs, Currencies, Futures
Extensive trading capabilities and global investment tracking.
Access market data 24 hours a day, six days a week and invest in global stocks, options, futures, currencies, bonds and funds from one single account.
CIBC Investor's Edge
Finder Rating:
4 / 5
$4.95 - $6.95
$0 if conditions met, otherwise $100/year
Stocks, Bonds, Options, Mutual Funds, ETFs
Get up to $2,000 cash back. Conditions apply. Offer ends March 1, 2022.
An intuitive and easy-to-use platform with access to a variety of tools that help you make smart decisions and trade with confidence.
Finder Rating:
4.2 / 5
$4.95 - $9.95
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs, International Equities, Precious Metals
Get $50 in free trades when you fund your account with a minimum of $1,000.
Opt for self-directed investing and save on fees or get a pre-built portfolio and take some of the guesswork out.
Qtrade Direct Investing
Finder Rating:
4.1 / 5
$6.95 - $8.75
$0 if conditions met, otherwise $25/quarter
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs
Get a $50 bonus when you open a new RRSP, TFSA or RESP and start pre-authorized contributions of at least $200/month. Valid until March 1, 2022.
Qtrade Direct Investing offers low trading commissions and an easy-to-use platform with access to powerful tools and a wide selection of investment options. Trade 100 ETFs free of charge and thousands more for $8.75 or lower.

Compare up to 4 providers

Online stock trading

MeiraGTx price performance over time

Historical closes compared with the close of $18.49 from 2022-01-14

1 week (2022-01-07) -14.12%
1 month (2021-12-16) -7.09%
3 months (2021-10-15) 29.48%
6 months (2021-07-16) 27.34%
1 year (2021-01-15) 13.02%
2 years (2020-01-16) -10.33%
3 years (2019-01-16) 72.32%
5 years (2017-01-12) N/A

MeiraGTx financials

Revenue TTM $20.4 million
Gross profit TTM $15.6 million
Return on assets TTM -16.41%
Return on equity TTM -43.67%
Profit margin 0%
Book value $4.24
Market capitalisation $906.8 million

TTM: trailing 12 months

MeiraGTx share dividends

We're not expecting MeiraGTx to pay a dividend over the next 12 months.

MeiraGTx share price volatility

Over the last 12 months, MeiraGTx's shares have ranged in value from as little as $11.6 up to $24.895. A popular way to gauge a stock's volatility is its "beta".

MGTX.US volatility(beta: 1.6)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while MeiraGTx's is 1.597. This would suggest that MeiraGTx's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

MeiraGTx overview

MeiraGTx Holdings plc, a clinical stage gene therapy company, focusing on developing treatments for patients living with serious diseases. The company develops various therapies for ocular diseases, including inherited blindness, as well as Xerostomia following radiation treatment for head and neck cancers; degenerative diseases; neurodegenerative diseases, such as amyotrophic lateral sclerosis; and Parkinson's diseases. Its programs in clinical development include Phase 1/2 clinical stage programs in Achromatopsia, X-Linked Retinitis Pigmentosa, RPE65-deficiency, and radiation-induced Xerostomia, as well as Parkinson's program. The company also focuses on initiating a clinical program in xerostomia related to Sjogren's syndrome and have preclinical programs in neurodegenerative diseases. It has a research collaboration agreement with Janssen Pharmaceuticals, Inc. to develop regulatable gene therapy treatment using the company's proprietary riboswitch technology. The company was incorporated in 2015 and is based in New York, New York.

Stocks similar to MeiraGTx

Frequently asked questions

Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, CFDs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading CFDs and forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.

More on investing

More guides on Finder

Go to site